Diligence memo · auto-generated · as of July 2, 2026
Exponential Genomics Inc.
Exponential Genomics Inc. has raised $600K over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Exponential Genomics Inc. operates in Biotech, based in VANCOUVER.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Exponential Genomics Inc. has raised $600K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $600K on 2020-06-16.
Most recent recorded round closed around 2020-06-16.
Valuation (modeled)modeled
Provath models Exponential Genomics Inc. at approximately $33M (range $320K–$376M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 6.0 yr ago; this sector typically re-raises about every 11 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 72% of Biotech peers (233 compared).
Modeled value ranks above 79% of those peers.
Closest niche peers: CMTx Biotech, Inc., Empire Genomics Corp., Aniluxx Biotechnology, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.